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•  Several chronic pain conditions, such as 
temporomandibular disorders (TMD), are more 
common in women than in men1,2 although the 
biological mechanisms responsible for this gender 
disparity are poorly understood 
•  Observational studies suggest that TMD pain is 
greatest during the late luteal phase of the menstrual 
cycle and during menses when estrogen levels 
quickly decline3,4  
•  Also, women with TMD who use hormonal 
contraception report greater levels of daily pain 
compared to women not taking hormonal 
contraception 
•  The aim of this study is to evaluate gynecological 
characteristics that are putative risk factors for TMD: 
parity, use of hormonal contraception, and self-
reported pain levels and psychological symptoms 
over the course of the menstrual cycle 
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Figure 1. PRISM symptoms vary over the course of the menstrual 
cycle. The mean level of each symptom is shown for late luteal 
phase and early follicular phase  
Table 1. TMD cases and controls according to 
putative risk factors and associated odds ratios 
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•  Current use of hormonal contraception (HC) was 
weakly associated with TMD, and the association was 
no longer statistically significant after adjusting for 
race and age 
•  Greater odds of TMD was associated with use of HC 
for five years or longer and with using HC to treat 
pain, however using HC for other reasons (bleeding, 
contraception) was not significantly associated with 
case status  
•  Self-reported dysmenorrhea was associated with a 
higher odds of TMD  
•  Self-reported severe premenstrual symptoms (PMS) 
were also associated with a higher odds of TMD 
•  A weak association between current HC use and 
TMD case status was noted, however a stronger 
association was observed with long-term use (>5 
years) and TMD case status 
•  Dysmenorrhea and severe PMS symptoms were both 
strongly associated with TMD 
•  These results suggest that female reproductive 
hormones might contribute to chronic TMD and 
provide evidence that pain during menstruation may 
increase women’s risk of developing more serious 
chronic pain conditions 
•  Further study on the association between HC use and 
TMD is needed 
  
Introduction 
Results 
•  The OPPERA (Orofacial Pain: Prospective Evaluation and 
Risk Assessment) project was designed to identify risk 
factors for TMD 
•  Subjects were recruited at four U.S. study sites from 
2006-2008 
•  This analysis used data from female participants in 
OPPERA’s baseline case-control study: 155 women with 
chronic TMD and 925 women without TMD  
•  Cases had ≥6 month history of TMD symptoms and had 
tender muscles/joints during examination using RDC/
TMD criteria5. Controls had no history of TMD 
symptoms6 
•  Each participant provided questionnaires to evaluate 
their gynecological history in addition to a Prospective 
Record of the Impact and Severity of Menstruation 
(PRISM) diary to investigate pain and psychological 
distress over 28 days (i.e. one menstrual cycle) 
 
Putative	  
risk	  
factor	  
	  Category	   TMD	  
controls	  
TMD	  
cases	  
Fully	  adjusted	  
odds	  ratios	  
(95%	  
con>idence	  
intervals)	  
P	  value	  
History	  of	  HC	   Current	  user	   152	   36	   1.9	  (1.1,	  3.5)	   0.0003	  Former	  user	   1.7	  (1.0,	  2.7)	  466	   90	  Never	  used	  (ref)	   300	   26	  Main	  reason	  for	  HC	  use	   Pain	   90	   25	   2.5	  (1.3,	  4.6)	   0.0001	  Other	   520	   103	   1.7	  (1.0,	  2.7)	  Never	  used	  (ref)	   300	   26	  Parity	   No	  children	   672	   101	   0.5	  (0.3,	  0.7)	   0.048	  One	  or	  more	  children	   250	   54	  Pain	  during	  menstruation	   Severe	   52	   12	   2.8	  (1.3,	  	  6.3)	   0.0057	  Moderate	   231	   57	   2.2	  (1.3,	  	  3.7)	  Mild	   416	   61	   1.3	  (0.8,	  	  2.1)	  None	  (ref)	   223	   25	  Pre-­‐menstrual	  symptom	  severity	  
Severe	   45	   15	   2.4	  (1.2,	  	  4.9)	   0.103	  Moderate	   212	   35	   1.0	  (0.6,	  	  1.7)	  Mild	   405	   67	   0.9	  (0.6,	  	  1.4)	  None	  (ref)	   248	   36	  
•  Women with TMD reported higher levels of pain in 
multiple body regions as well as higher psychological 
distress throughout the menstrual cycle compared to 
women without TMD 
•  Women with TMD also reported more severe pain in 
several bodily regions (particularly the pelvic region) 
during the follicular phase of the menstrual cycle than 
TMD-free women 
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!Figure!1:!This!figure!shows!how!each!PRISM!symptom!varies!over!the!course!of!the!menstrual!cycle.!The!mean!level!of!each!symptom!is!shown!for!late!luteal!phase!and!early!follicular!phase!(as!well!as!for!the!“baseline”!category,!which!is!defined!be!neither!late!luteal!nor!early!follicular!phase).!These!values!are!plotted!separately!for!TMD!cases!and!controls.!The!height!of!each!bar!is!the!mean!value,!and!the!bars!represent!a!95%!confidence!interval.!The!estimates!of!the!means!were!adjusted!for!study!site,!and!a!random!effect!was!included!for!each!subject!to!adjust!for!repeated!measurements.!Note!that!the!yLaxes!of!the!plots!are!on!different!scales!for!each!symptom,!so!the!heights!of!the!bars!for!different!symptoms!are!not!comparable!to!one!another.!
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